Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
Amount Raised
$7.5 Million
Round Type
Venture
DurhamBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
Precision BioSciences, Inc. received an initial $7.5 million cash payment and equity investment from TG Therapeutics, Inc. for an exclusive license to develop Azercabtagene Zapreleucel (azer-cel) for autoimmune diseases, and other indications outside of cancer. This is the first in a series of payments, with Precision to receive a total of $17.5 million in upfront and potential near-term payments as part of the consideration for this license.
Quick answer
Precision BioSciences raised $7.5 Million in a funding round, dated February 12, 2024. Investors: TG Therapeutics. Precision BioSciences is based in Durham, North Carolina, United States.
- How much did Precision BioSciences raise?
- Precision BioSciences raised $7.5 Million in a funding round on February 12, 2024.
- Who invested in Precision BioSciences?
- TG Therapeutics is named as investors in this round.
- What does Precision BioSciences do?
- Precision is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller..
- Where is Precision BioSciences based and how big is it?
- Precision BioSciences is based in Durham, North Carolina, United States. Fundz records about 106 employees.
- Who are the decision-makers at Precision BioSciences?
- Fundz holds 5 contacts at Precision BioSciences, including the Chief of Staff to the CEO / Commercial Head. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Precision BioSciences that raised within 45 days of this round, from Fundz verified event records.
- Lexeo Therapeutics raised $95M on March 15, 2024.
- VolitionRx raised $100K (Pre-Seed) on March 12, 2024.
- Vaccinex raised $1.2M (Seed) on March 28, 2024.
- Avalo Therapeutics raised $131M on March 27, 2024.
- Nouscom raised $76M (Series C) on March 21, 2024.
- Enliven Therapeutics raised $90M on March 21, 2024.
Who to call at Precision BioSciences, and when
A new round usually means Precision BioSciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Precision BioSciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Precision BioSciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Precision BioSciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Precision BioSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Precision BioSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.